Daniel S. Jonas - Feb 25, 2022 Form 4 Insider Report for CONMED Corp (CNMD)

Role
EVP Legal Affairs,Gen. Counsel
Signature
Daniel S. Jonas
Stock symbol
CNMD
Transactions as of
Feb 25, 2022
Transactions value $
-$531,328
Form type
4
Date filed
3/1/2022, 03:10 PM
Previous filing
Jan 5, 2022
Next filing
Mar 3, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNMD Common Stock Options Exercise $39.4K +500 +4.11% $78.76 12.7K Feb 25, 2022 Direct
transaction CNMD Common Stock Sale -$75K -500 -3.95% $150.03 12.2K Feb 25, 2022 Direct F1
transaction CNMD Common Stock Options Exercise $263K +3.34K +27.48% $78.76 15.5K Feb 25, 2022 Direct
transaction CNMD Common Stock Sale -$499K -3.34K -21.55% $149.41 12.2K Feb 25, 2022 Direct F2
transaction CNMD Common Stock Options Exercise $122K +1.25K +10.23% $97.69 13.4K Feb 25, 2022 Direct
transaction CNMD Common Stock Sale -$187K -1.25K -9.28% $150.00 12.2K Feb 25, 2022 Direct
transaction CNMD Common Stock Options Exercise $367K +3.76K +30.86% $97.69 15.9K Feb 25, 2022 Direct
transaction CNMD Common Stock Sale -$561K -3.76K -23.58% $149.46 12.2K Feb 25, 2022 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -500 -2% $0.00 24.5K Feb 25, 2022 Common Stock 500 $78.76 Direct F4
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -3.34K -13.64% $0.00 21.2K Feb 25, 2022 Common Stock 3.34K $78.76 Direct F4
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -1.25K -4.98% $0.00 23.8K Feb 25, 2022 Common Stock 1.25K $97.69 Direct F4
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -3.76K -15.81% $0.00 20K Feb 25, 2022 Common Stock 3.76K $97.69 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.00 to $150.16. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.40 to $149.63. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.40 to $149.56. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F4 The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period